Update on the antibiotic supply bottlenecks in Germany: The autumn and the new winter season of 2024/25 are approaching. Still, the measures the Federal Ministry of Health (BMG) already took with the law against supply bottlenecks (ALBVVG) didn’t get the results the German patients and medical professionals expected. Mathias Arnold, ABDA’s vice president comments “How the situation with children’s medicines will develop in the cold season that begins soon is not yet foreseeable. Demand depends on the incidence of infection”
Pro Generika Managing Director Bork Bretthauer also warns: “The ALBVVG is not able to solve the problem of supply bottlenecks,” said Managing Director Bork Bretthauer.
Now the chairman of the Hessian Pharmacists’ Association (HAV), Holger Seyfarth, joins his colleagues: “Due to massive antibiotic supply bottlenecks and inadequate political measures, public pharmacies can no longer fully fulfill their sovereign mandate to supply people in Germany with medicines.” In his letter to Minister Lauterbach, he wrote a few appropriate measures that need to be taken. Among them are minimum stockpiling, diversification of suppliers, and a “state-supervised system for the early detection of supply gene shortages”. Also, On-site pharmacies need to receive extensive logistical and financial support for the stockpiling of critical prescription drugs.
Source: Three demands: Supply bottlenecks: HAV writes to Lauterbach (deutsche-apotheker-zeitung.
Disclaimer:
As a service to our readers, MVS Pharma GmbH publishing provides access to our archived content library in our blog. Please note the date of the last review or update on all articles. No content on this site should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
MVS Pharma GmbH will soon be launching an omega-3 dietary supplement onto the European market that has been developed for the highest quality standards in terms of oxidation avoidance and therefore greatest bioavailability. In addition, in vitro studies are currently underway at the University of Ulm, in which Professor Dr. Rüdiger Groß tested a patented mouth and nose spray (Virudol) that can eliminate various flu viruses based on natural substances. In addition, MVS has a wholesale license and has specialized in sourcing much-needed medicines such as Amoxicillin, Salbutamol, etc. from India through its local branch with a focus on local quality and safety testing, compliance with international GMP regulations and the highest quality level of user security (examples of local language brochures, identical units of measurement, batch control and full tracking, etc.).
